Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value
Ranjit Ranbhor,1 Priyanka Kulkarni2 1Pergament and Cepeda LLC, Florham Park, NJ, 07932, USA; 2Feliciano School of Business, Montclair State University, Montclair, NJ, 07043, USACorrespondence: Ranjit Ranbhor, Email ranjitranbhor@gmail.comBackground: The increasing prominence of biosimilars in health...
Saved in:
| Main Authors: | Ranbhor R, Kulkarni P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Biologics: Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/evaluating-biosimilar-development-projects-an-analytical-framework-uti-peer-reviewed-fulltext-article-BTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRITICAL ANALYSIS OF THE CONCEPT OF NET PRESENT VALUE OF INVESTMENTS PROJECTS
by: A. Kuznetsov
Published: (2018-04-01) -
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product
by: Hans C. Ebbers, et al.
Published: (2025-04-01) -
Enhancing Spectrum License Valuation With Probabilistic Net Present Value Analysis
by: Gabriel Zauza Braun, et al.
Published: (2025-01-01) -
Enhancing Financial Decision-Making: Real Options Complementing the Net Present Value Technique in the Financial Services Sector
by: Ferina Marimuthu, et al.
Published: (2024-12-01) -
Selecting the best-value biosimilar in emerging countries
by: Gilberto Castañeda-Hernández
Published: (2024-09-01)